Follow
Louis-Charles Fortier
Title
Cited by
Cited by
Year
Importance of prophages to evolution and virulence of bacterial pathogens
LC Fortier, O Sekulovic
Virulence 4 (5), 354-365, 2013
5672013
PhageTerm: a tool for fast and accurate determination of phage termini and packaging mechanism using next-generation sequencing data
JR Garneau, F Depardieu, LC Fortier, D Bikard, M Monot
Scientific reports 7 (1), 8292, 2017
4722017
Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10 …
L Villeneuve, H Girard, LC Fortier, JF Gagné, C Guillemette
Journal of Pharmacology and Experimental Therapeutics 307 (1), 117-128, 2003
2342003
Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways
J Mulhbacher, E Brouillette, M Allard, LC Fortier, F Malouin, ...
PLoS pathogens 6 (4), e1000865, 2010
2022010
Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver
H Girard, O Bernard, LC Fortier, L Villeneuve, Q Hao, DJ Greenblatt, ...
Pharmacogenetics and Genomics 14 (8), 501-515, 2004
1942004
Cyclic di-GMP riboswitch-regulated type IV pili contribute to aggregation of Clostridium difficile
E Bordeleau, EB Purcell, DA Lafontaine, LC Fortier, R Tamayo, V Burrus
Journal of bacteriology 197 (5), 819-832, 2015
1532015
c-di-GMP Turn-Over in Clostridium difficile Is Controlled by a Plethora of Diguanylate Cyclases and Phosphodiesterases
E Bordeleau, LC Fortier, F Malouin, V Burrus
PLoS genetics 7 (3), e1002039, 2011
1332011
In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
K Selle, JR Fletcher, H Tuson, DS Schmitt, L McMillan, GS Vridhambal, ...
MBio 11 (2), 10.1128/mbio. 00019-20, 2020
1282020
Phage production and maintenance of stocks, including expected stock lifetimes
LC Fortier, S Moineau
Bacteriophages: Methods and Protocols, Volume 1: Isolation, Characterization …, 2009
1282009
Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
M Gonzales, J Pepin, EH Frost, JC Carrier, S Sirard, LC Fortier, ...
BMC infectious diseases 10, 1-7, 2010
1252010
Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes
S Sirard, L Valiquette, LC Fortier
Journal of clinical microbiology 49 (12), 4040-4046, 2011
1232011
Morphological and Genetic Diversity of Temperate Phages in Clostridium difficile
LC Fortier, S Moineau
Applied and environmental microbiology 73 (22), 7358-7366, 2007
1212007
Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens
O Sekulovic, M Meessen-Pinard, LC Fortier
Journal of bacteriology 193 (11), 2726-2734, 2011
1202011
Regulation of stress response in Oenococcus oeni as a function of environmental changes and growth phase
J Guzzo, MP Jobin, F Delmas, LC Fortier, D Garmyn, R Tourdot-Maréchal, ...
International journal of food microbiology 55 (1-3), 27-31, 2000
1172000
Evidence of In Vivo Prophage Induction during Clostridium difficile Infection
M Meessen-Pinard, O Sekulovic, LC Fortier
Applied and environmental microbiology 78 (21), 7662-7670, 2012
1032012
Novel high-molecular-weight, R-type bacteriocins of Clostridium difficile
D Gebhart, SR Williams, KA Bishop-Lilly, GR Govoni, KM Willner, A Butani, ...
Journal of bacteriology 194 (22), 6240-6247, 2012
972012
The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver
H Girard, L Villeneuve, LC Fortier, P Caron, Q Hao, LL von Moltke, ...
Drug metabolism and disposition 34 (7), 1220-1228, 2006
772006
Genome Sequence and Global Gene Expression of Q54, a New Phage Species Linking the 936 and c2 Phage Species of Lactococcus lactis
LC Fortier, A Bransi, S Moineau
Journal of bacteriology 188 (17), 6101-6114, 2006
762006
UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver
H Girard, J Thibaudeau, LC Fortier, L Villeneuve, P Caron, Q Hao, ...
Hepatology 42 (2), 448-457, 2005
722005
Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort
CN Abou Chakra, A McGeer, AC Labbé, AE Simor, WL Gold, MP Muller, ...
Clinical Infectious Diseases 61 (12), 1781-1788, 2015
692015
The system can't perform the operation now. Try again later.
Articles 1–20